Poseida Therapeutics, Inc.
NASDAQ: PSTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mark J. Gergen
- Employees
- 350
- Headquarters
- San Diego, United States
- IPO year
- 2020
- Market cap
- $925.9M
- Website
- https://www.poseida.com
Loading PSTX…
Loading profile data…Frequently asked questions about PSTX
What does Poseida Therapeutics, Inc. (PSTX) do?
Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet medical needs. Its pipeline prominently features several advanced cell therapies. For instance, P-PSMA-101, an autologous CAR-T cell therapy, is curre...
Where does PSTX trade?
Poseida Therapeutics, Inc. (PSTX) trades on the NASDAQ Global Select.
What sector is PSTX in?
Poseida Therapeutics, Inc. (PSTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Poseida Therapeutics, Inc.?
Mark J. Gergen is the chief executive officer of Poseida Therapeutics, Inc. (PSTX).
Where is Poseida Therapeutics, Inc. headquartered?
Poseida Therapeutics, Inc. is headquartered in United States.
Does PSTX pay a dividend?
Poseida Therapeutics, Inc. (PSTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSTX go public?
Poseida Therapeutics, Inc. (PSTX) completed its initial public offering in 2020.